Reportedly, South Korean retail investors have bought a net $2.8 billion worth of Tesla Inc. (TSLA), stock this year amid the electric-vehicle maker’s worst slump on record. According to data from Korea Securities Depository, Day traders have added $160 million in Tesla shares this month through Dec. 27, on track for the third month of net purchases. Traders continued to buy even as the stock tumbled 44% in December, reporting its worst-ever month.
The EV giant remains the most popular overseas stock among Korean retail traders, with investment sharply increasing during the pandemic.
Visit the VP Watchlist to learn more about Tesla (TSLA), Apple (AAPL), and other companies highlighted in our targeted list.
Stay Informed! Stay Competitive! Please join us at Vista Partners, receive our FREE email updates throughout the week, and view our exclusive content and research.
DID YOU KNOW?
Fertility rates have hit a record low in the United States. The latest US government fertility statistics come from 2019, and they estimate there were 58.2 births year per 1,000 women of childbearing age (defined by the CDC as women between ages 15 and 44).
If you have ever struggled with infertility issues, or know someone who has, you are probably well aware of how demoralizing it can be. Imagine for a moment spending thousands of dollars and months of intensive medical procedure only to end up empty handed, exhausted, sad, and defeated because after all of that time, work, and money, you still don’t have a baby. That’s an incredibly difficult situation, and it’s becoming more common each passing year. Likewise, the need for more effective, less invasive infertility treatment options is increasing with each passing year. This is the sole focus of medtech company INVO Bioscience (NASDAQ: INVO). Learn more by reading the following story that we published recently.
